WADE JEFFREY L has filed 22 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 307000 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on July 08, 2024.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and COO | A | Stock Option (Right to Buy) | 307000 | $0.00 | 307,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Common Stock | 11177 | $0.00 | 275,518.0000 | 0 | 4.23% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Common Stock | 37274 | $0.00 | 312,792.0000 | 0 | 13.53% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Common Stock | 49113 | $0.00 | 361,905.0000 | 0 | 15.70% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | F | Common Stock | 37691 | $2.62 | 324,214.0000 | 0 | 10.41% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 11177 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 37274 | $0.00 | 37,273.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 49113 | $0.00 | 98,227.0000 | 0 | 33.33% | 0.00% |
| Feb. 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | A | Restricted Stock Units | 314320 | $0.00 | 314,320.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | A | Stock Option (Right to Buy) | 314320 | $0.00 | 314,320.0000 | 0 | 9999.99% | 0.00% |
| Sept. 14, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | P | Common Stock | 10000 | $1.38 | 264,341.0000 | 0 | 3.93% | 0.00% |
| June 20, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | P | Common Stock | 10000 | $2.34 | 252,341.0000 | 0 | 4.13% | 0.00% |
| June 20, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | P | Common Stock | 2000 | $2.33 | 254,341.0000 | 0 | 0.79% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Common Stock | 30467 | $0.00 | 224,147.0000 | 0 | 15.73% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Common Stock | 11176 | $0.00 | 235,323.0000 | 0 | 4.99% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Common Stock | 37273 | $0.00 | 272,596.0000 | 0 | 15.84% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | F | Common Stock | 30255 | $2.17 | 242,341.0000 | 0 | 11.10% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 30467 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 11176 | $0.00 | 11,177.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | M | Restricted Stock Units | 37273 | $0.00 | 74,547.0000 | 0 | 33.33% | 0.00% |
| Feb. 9, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | A | Restricted Stock Units | 147340 | $0.00 | 147,340.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | WADE JEFFREY L | President and CFO | A | Stock Option (Right to Buy) | 442030 | $0.00 | 442,030.0000 | 0 | 9999.99% | 0.00% |